NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/16/2022
Back to search
Official data from USPTO
PROCELLEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PROCELLEX
ST13
US500000077226905Class
1, 9, 42
Filing
77226905
Registration
4004202
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
03/16/2022
Trademark type
Word
Nice classes
1, 9, 42
Filing date
07/11/2007
Registration date
08/02/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/16/2022
Last transaction
03/16/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Carmiel, IL
Examiner
STEEL, ALYSSA PALADINO
Law office
L70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
PROTALIX LTD.
Representatives
JODY H. DRAKE SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 1Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalbiochemicalbiological and biotechnological preparations and substances for scientific and medical research userecombinant vectors for cloning; proteins and reagents for scientific and medical research usefor use in recombinant protein expression in cells; recombinant vectors and reagents for expressing recombinant DNA for industrialscientificmedical research use; chemicalbiochemicalbiological and biotechnological preparations and substancesrecombinant vectors for industrialscientificmedical research use in laboratoriesdiagnostics and analytics; chemicalbiochemicalbiological and biotechnological preparations and substancescell growth support structures medium and substrates for use in cell cultures for industrialscientific and medical research; chemicalbiochemicalbiological and biotechnological preparations and substances for use in the manufacture of medicinespharmaceuticalsdiagnosticsvaccinesantibodies and biological molecules from recombinant proteins or peptides expressed in cell culturescell growth support structures and substrates for use in cell culturesrecombinant vectors for cloning and reagents for expression of recombinant proteins; none of the foregoing being diagnostic assays for scientificresearchclinicalmedical laboratory use
Class 9
Bioreactor for cell culturing
Class 42
Providing medical and scientific research equipment to others for culturing cells used to produce biopharmaceuticalsrecombinant proteins; research and development for others in the field of genetically engineered plants and plant cells for producing biopharmaceuticalsrecombinant proteins; development of new technology for others in the field of recombinant biotechnology; product research and development; scientific research and industrial research for othersdrug discoverycell discoverydiscovery of recombinant proteinsgene researchenzyme researchmolecular researchgenomics and gene expression research and development; technical consultation in the field of biotechnology and in the field of recombinant production technology
Publications
History of USPTO decisions and trademark events.
45 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/16/2022
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/16/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/15/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
11/04/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/02/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/10/2017
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/10/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/10/2017
E815
TEAS SECTION 8 & 15 RECEIVED
05/16/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
08/02/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/17/2011
PUBO
PUBLISHED FOR OPPOSITION
05/17/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
04/12/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/11/2011
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/07/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2011
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/05/2011
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/27/2010
GNRT
NON-FINAL ACTION E-MAILED
10/27/2010
CNRT
NON-FINAL ACTION WRITTEN
10/27/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/22/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/22/2010
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/23/2010
GNRT
NON-FINAL ACTION E-MAILED
04/23/2010
CNRT
NON-FINAL ACTION WRITTEN
04/23/2010
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
04/21/2010
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/20/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
04/20/2009
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
10/17/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/17/2008
GNSL
LETTER OF SUSPENSION E-MAILED
04/17/2008
CNSL
SUSPENSION LETTER WRITTEN
04/17/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/16/2008
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2007
GNRT
NON-FINAL ACTION E-MAILED
10/16/2007
CNRT
NON-FINAL ACTION WRITTEN
10/16/2007
DOCK
ASSIGNED TO EXAMINER
10/15/2007
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/11/2007
ALIE
ASSIGNED TO LIE
10/11/2007
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/30/2007
NWAP
NEW APPLICATION ENTERED
07/16/2007
Continuous trademark protection
Get notified about every new filing that threatens PROCELLEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.